| Financial Year |
March 31 2023 |
| Monetary Funds |
585,295,682.75 |
| Held-for-trading Financial Assets |
39,262,032.82 |
| Notes Receivable |
9,850,668.89 |
| Accounts Receivable |
377,779,192.00 |
| Advances to Suppliers |
39,705,207.57 |
| Other Receivables |
142,327,122.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
235,299,057.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,387,352.12 |
| Total Current Assets |
2,138,862,320.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
888,291.02 |
| Investment Properties |
67,580,422.80 |
| Fixed Assetes |
200,736,352.93 |
| Under-construction Projects |
2,932,557.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,502,581.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
21,015,147.80 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
385,365,775.25 |
| Total Assets |
2,524,228,095.72 |
| Short-Term Loans |
572,880,423.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
59,157,942.62 |
| Accounts Payable |
497,947,540.54 |
| Accounts Received In Advance |
4,356,864.00 |
| Employee Compensation Payable |
18,321,679.52 |
| Taxes Payable |
12,443,182.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,069,069.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,853,034.31 |
| Other Current Liabilities |
26,857,400.47 |
| Sub-Total of Current Liabilities |
1,238,208,916.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,564,286.13 |
| Total Liabilities |
1,245,773,202.37 |
| Paid-In Capital(Or Share Stock) |
1,341,764,974.00 |
| Capital Surplus |
993,888,777.58 |
| Surplus Reserve |
35,207,562.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,087,627,324.96 |
| Minority Stockholder's Interest |
-4,563,513.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,283,018,406.78 |
| Owner's Equity（Stockholder's Equity） |
1,278,454,893.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,524,228,095.72 |
